<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04013061</url>
  </required_header>
  <id_info>
    <org_study_id>PHRCI/2018/GL-01</org_study_id>
    <nct_id>NCT04013061</nct_id>
  </id_info>
  <brief_title>Impact of a Pharmacist-anesthesiologist Collaboration During Anesthesia Consultation on Prevention of Perioperative Medication Errors of Patients in Programmed Surgery</brief_title>
  <acronym>PREVEMCA</acronym>
  <official_title>Impact of a Pharmacist-anesthesiologist Collaboration During Anesthesia Consultation on Prevention of Perioperative Medication Errors of Patients in Programmed Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Universitaire de Nīmes</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre Hospitalier Universitaire de Nīmes</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigators will evaluate the efficiency of a pharmacist-anesthesiologist collaboration
      in the anesthetic consultation in the prevention of medical errors perioperatively in
      patients undergoing scheduled surgery
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">February 25, 2020</start_date>
  <completion_date type="Anticipated">March 2021</completion_date>
  <primary_completion_date type="Anticipated">February 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Rate of patients with at least one medication error for chronic treatment</measure>
    <time_frame>48 hours post-admission</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Nature of medication error</measure>
    <time_frame>48 hours post-admission</time_frame>
    <description>According to REMED (Revue des Erreurs liées aux Médicaments Et Dispositifs médicaux) classification</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rate of medication errors corrected</measure>
    <time_frame>48 hours post-admission</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rate of prescriptions respecting the Société Française d'Anesthésie et de Réanimation recommendations</measure>
    <time_frame>48 hours post-admission</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rate of corrected medication errors or major, critical or catastrophic severity according to HAS 2018</measure>
    <time_frame>48 hours post-admission</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rate of patients whose usually prescribed medication at admission is not available for them in the evening following surgery</measure>
    <time_frame>48 hours post-admission</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rate of medications not available on the establishment's therapeutic book and not brought by the patient</measure>
    <time_frame>48 hours post-admission</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Duration in hospital</measure>
    <time_frame>End of hospitalization (max 30 days)</time_frame>
    <description>Days</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rate of delay or cancellation of surgery linked to preoperational medication error</measure>
    <time_frame>End of study (13 months)</time_frame>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">378</enrollment>
  <condition>Surgical Procedures, Operative</condition>
  <arm_group>
    <arm_group_label>Standard consultation</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Pharmacist-anesthesiologist consultation</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Pluridisciplinary consultation</intervention_name>
    <description>Pharmacist-anesthesiologist team will be present during the anesthetic consultation</description>
    <arm_group_label>Pharmacist-anesthesiologist consultation</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients hospitalized for a programmed surgery in the service of urology or digestive
        surgery at the CHU Nimes or orthopedic surgery in the CHU Montpellier or Toulouse
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  The patient must have given their free and informed consent

          -  The patient must be a member or beneficiary of a health insurance plan

          -  The patient has at least one chronic medication prescription (associated with a
             chronic illness)

          -  The patient is hospitalized for a programmed surgery in the service of urology or
             digestive surgery at the CHU Nimes or orthopedic surgery in the CHU Montpellier or
             Toulouse

        Exclusion Criteria:

          -  The subject is participating in an interventional study, or is in a period of
             exclusion determined by a previous study

          -  The subject refuses to sign the consent

          -  It is impossible to give the subject informed information

          -  The patient is under safeguard of justice or state guardianship

          -  The patient is having ambulatory programmed surgery

          -  The patient has an anesthetic consultation in a different health establishment
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
  </eligibility>
  <overall_official>
    <last_name>Géraldine Leguelinel-Blache</last_name>
    <role>Study Director</role>
    <affiliation>CHU Nimes</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Géraldine Leguelinel-Blache</last_name>
    <phone>04 66 68 31 04</phone>
    <email>geraldine.leguelinel@chu-nimes.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>CHU de Montpellier</name>
      <address>
        <city>Montpellier</city>
        <zip>34090</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Anne Jalabert</last_name>
      <phone>04 67 33 67 33</phone>
      <email>a-jalabert@chu-montpellier.fr</email>
    </contact>
    <investigator>
      <last_name>Anne Jalabert</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Maxime Villiet</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Philippe Biboulet</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU de Nimes</name>
      <address>
        <city>Nîmes</city>
        <zip>30029</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Anissa Megzari</last_name>
      <phone>04.66.68.42.36</phone>
      <email>drc@chu-nimes.fr</email>
    </contact>
    <investigator>
      <last_name>Géraldine Leguelinel-Blache</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Célia Trouilleux-Py</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jean-Maire Kinowski</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Clarisse Roux-Marson</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Philippe Cuvillon</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU de Toulouse</name>
      <address>
        <city>Toulouse</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Philippe Cestac</last_name>
      <phone>05 61 32 28 85</phone>
      <email>cestac.p@chu-toulouse.fr</email>
    </contact>
    <investigator>
      <last_name>Philippe Cestac</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Julien Jouglen</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Elodie Civade</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Mathias Ade</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Olivier Fourcade</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>March 2020</verification_date>
  <study_first_submitted>July 5, 2019</study_first_submitted>
  <study_first_submitted_qc>July 5, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">July 9, 2019</study_first_posted>
  <last_update_submitted>March 6, 2020</last_update_submitted>
  <last_update_submitted_qc>March 6, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">March 9, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

